Novanta Inc, together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products for photonics-based applications, such as industrial material processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.
Read More…
Industry, Sector and Symbol
Industry Miscellaneous electrical machinery, equipment, & supplies
Sub-IndustryN/A
SectorComputer and Technology
Phone781-266-5700
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$614.34 million
Profitability
Miscellaneous
Employees2,133
Next Earnings Date11/5/2019 (Estimated)
OptionableOptionable
Novanta (NASDAQ:NOVT) Frequently Asked Questions
What is Novanta's stock symbol?
Novanta trades on the NASDAQ under the ticker symbol "NOVT."
How were Novanta's earnings last quarter?
Novanta Inc (NASDAQ:NOVT) posted its quarterly earnings results on Tuesday, August, 6th. The technology company reported $0.54 EPS for the quarter, hitting the Zacks' consensus estimate of $0.54. The technology company had revenue of $155.10 million for the quarter, compared to analysts' expectations of $154.47 million. Novanta had a net margin of 7.76% and a return on equity of 19.49%. The business's revenue for the quarter was up 3.1% on a year-over-year basis. During the same period in the prior year, the business posted $0.51 earnings per share. View Novanta's Earnings History.
When is Novanta's next earnings date?
What guidance has Novanta issued on next quarter's earnings?
Novanta issued an update on its fourth quarter earnings guidance on Tuesday, August, 6th. The company provided earnings per share guidance of $0.61-0.63 for the period, compared to the Thomson Reuters consensus estimate of $0.68. The company issued revenue guidance of $166-169 million, compared to the consensus revenue estimate of $167.54 million.
What price target have analysts set for NOVT?
1 Wall Street analysts have issued twelve-month price targets for Novanta's stock. Their forecasts range from $81.00 to $81.00. On average, they anticipate Novanta's share price to reach $81.00 in the next twelve months. This suggests a possible upside of 10.8% from the stock's current price. View Analyst Price Targets for Novanta.
What is the consensus analysts' recommendation for Novanta?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Novanta in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Novanta.
Has Novanta been receiving favorable news coverage?
Media headlines about NOVT stock have trended positive this week, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Novanta earned a media sentiment score of 2.5 on InfoTrie's scale. They also assigned news coverage about the technology company a news buzz of 6.0 out of 10, meaning that recent news coverage is somewhat likely to have an effect on the stock's share price in the near future. View News Stories for Novanta.
Are investors shorting Novanta?
Novanta saw a increase in short interest in the month of July. As of July 15th, there was short interest totalling 679,200 shares, an increase of 18.6% from the June 15th total of 572,900 shares. Based on an average daily volume of 147,500 shares, the days-to-cover ratio is currently 4.6 days. Approximately 2.0% of the shares of the stock are sold short. View Novanta's Current Options Chain.
Who are some of Novanta's key competitors?
Some companies that are related to Novanta include CAE (CAE), Integer (ITGR), Energizer (ENR), Spectrum Brands (SPB), Atkore International Group (ATKR), Electro Scientific Industries (ESIO), Ultralife (ULBI), Highpower International (HPJ), Arotech (ARTX), Flux Power (FLUX), Sono-Tek (SOTK), Polar Power (POLA), CBAK Energy Technology (CBAT), CBAK Energy Technology (CBAK) and Security Devices International (SDEV).
What other stocks do shareholders of Novanta own?
Who are Novanta's key executives?
Novanta's management team includes the folowing people:
- Mr. Matthijs Glastra, CEO & Director (Age 50)
- Mr. Robert J. Buckley, Chief Financial Officer (Age 45)
- Mr. Brian S. Young, Chief HR Officer (Age 50)
- Mr. Peter L. Chang, VP, Corp. Controller & Chief Accounting Officer (Age 54)
- Mr. Heinrich Dreyer, Group Pres of Minimally Invasive Surgery
Who are Novanta's major shareholders?
Novanta's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (8.80%), Price T Rowe Associates Inc. MD (7.98%), BlackRock Inc. (6.47%), BlackRock Inc. (6.47%), Wells Fargo & Company MN (4.43%) and William Blair Investment Management LLC (2.50%). Company insiders that own Novanta stock include Matthijs Glastra, Peter L Chang, Robert Buckley and Stephen W Bershad. View Institutional Ownership Trends for Novanta.
Which institutional investors are selling Novanta stock?
NOVT stock was sold by a variety of institutional investors in the last quarter, including Sandler Capital Management, Bank of New York Mellon Corp, Westwood Holdings Group Inc., Renaissance Technologies LLC, AXA, Mackenzie Financial Corp, Mackenzie Financial Corp and Paradice Investment Management LLC. Company insiders that have sold Novanta company stock in the last year include Matthijs Glastra, Peter L Chang, Robert Buckley and Stephen W Bershad. View Insider Buying and Selling for Novanta.
Which institutional investors are buying Novanta stock?
NOVT stock was purchased by a variety of institutional investors in the last quarter, including Invesco Ltd., Wasatch Advisors Inc., Nuveen Asset Management LLC, GW&K Investment Management LLC, Waddell & Reed Financial Inc., DekaBank Deutsche Girozentrale, Royal Bank of Canada and BlackRock Inc.. View Insider Buying and Selling for Novanta.
How do I buy shares of Novanta?
Shares of NOVT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Novanta's stock price today?
One share of NOVT stock can currently be purchased for approximately $73.08.
How big of a company is Novanta?
Novanta has a market capitalization of $2.57 billion and generates $614.34 million in revenue each year. The technology company earns $49.11 million in net income (profit) each year or $2.16 on an earnings per share basis. Novanta employs 2,133 workers across the globe.View Additional Information About Novanta.
What is Novanta's official website?
How can I contact Novanta?
Novanta's mailing address is 125 Middlesex Turnpike, Bedford MA, 01730. The technology company can be reached via phone at 781-266-5700 or via email at [email protected]
MarketBeat Community Rating for Novanta (NASDAQ NOVT)
MarketBeat's community ratings are surveys of what our community members think about Novanta and other stocks. Vote "Outperform" if you believe NOVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NOVT will underperform the S&P 500 over the long term. You may vote once every thirty days.
